|
|
|
| Clinical Efficacy of Vitamin B12 and Folic Acid in the Treatment of Megaloblastic Anemia Patients |
| SUN Xingwei |
| Department of Hematology and Oncology, Zhengzhou Second People's Hospital, Zhengzhou Henan 450000 |
|
|
|
|
Abstract 【Objective】To explore the clinical efficacy of vitamin B12 and folic acid in the treatment of megaloblastic anemia (MA) patients.【Methods】Clinical data of 50 MA patients treated with vitamin B12 and folic acid supplementation were collected. The patients' clinical manifestations, changes in hematological indicators, and treatment outcomes were analyzed.【Results】After treatment, the mean corpuscular volume (MCV) of the patients decreased, while hemoglobin (Hb), vitamin B12, and folic acid levels increased significantly compared to before treatment, with differences being statistically significant (P<0.05). The proportion of patients with symptoms such as fatigue, pallor, loss of appetite, weight loss, and neurological symptoms significantly decreased after treatment, with differences being statistically significant (P<0.05). Correlation analysis showed that vitamin B12 had the closest association with symptom improvement. Vitamin B12, folic acid, and Hb levels were negatively correlated with fatigue, pallor, loss of appetite, weight loss, and neurological symptoms (all P<0.05). MCV was positively correlated with the above symptoms (P<0.05).【Conclusion】Supplementation of vitamin B12 and folic acid can improve hematological indicators and clinical symptoms in MA patients, which vitamin B12 plays a key role in symptom improvement. When diagnosing and treating MA clinically, attention should be paid to the detection and supplementation of vitamin B12 levels.
|
|
Received: 02 November 2024
|
|
|
|
|
|
[1] TORREZ M, CHABOT‐RICHARDS D, BABU D, et al. How I investigate acquired megaloblastic anemia[J].Int J Lab Hematol,2022, 44(2): 236-247.
[2] 全红.巨幼细胞性贫血患者血清叶酸、维生素B12水平和骨髓细胞形态学检测及疾病严重程度的相关性[J].吉林医学,2023,44(12):3430-3433.
[3] DUTTA T K. Megaloblastic anemia[J].Ann Clin Med Case Rep,2023, 10(15): 1-5.
[4] 周剑峰,孙汉英,张义成.血液病诊疗指南[M].北京:科学出版社,2013:48-50.
[5] TANG L, MIAO J, WANG J B. Clinical characteristics of megaloblastic anemia with pancytopenia[J].Hematology,2024, 29(1): 2420407.
[6] YAN X, KONG J X, WANG J C, et al. Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review[J].BMC Pulm Med,2024, 24(1): 121.
[7] SAHOO S, SAHU N, DAS P, et al. Effect of megaloblastic anemia on hemoglobin A2 and diagnosis of β-thalassemia trait[J].Indian J Pathol Microbiol,2023, 66(2): 327-331.
[8] SOCHA D S, DESOUZA S I, FLAGG A,et al.Severe megaloblastic anemia: Vitamin deficiency and other causes[J].Cleve Clin J Med,2020,87(3):153-164.
[9] OPREA V D, BOJINCĂ V C, BĂLĂNESCU A R, et al. Paget's disease of bone and megaloblastic anemia in a 72 year old patient: A case report and systematic literature review[J].Exp Ther Med,2022, 23(4): 269.
[10] 朱永超,丁勇,李凯.慢性萎缩性胃炎患者血清维生素B12水平与周围神经病变的相关性分析[J].医学临床研究,2020,37(12):1886-1888.
[11] 黄璐,赵莉,尤金枝.甲钴胺对结直肠癌患者XELOX方案引起的外周神经病变的影响[J].医学临床研究,2022,39(12):1827-1829.
[12] ZHAO Y F, HUANG T T, WANG X, et al. Measurement for the area of red blood cells from microscopic images based on image processing technology and its applications in aplastic anemia, megaloblastic anemia, and myelodysplastic syndrome[J].Front Med(Lausanne),2022, 8: 796920.
[13] QI J, LI Y, DUAN L, et al. Analysis of cognitive dysfunction and its influencing factors in patients with megaloblastic anemia[J].Clin Med,2024, 5(3): 68-74. |
|
|
|
2025, Vol. 42 
